Acne Vulgaris and Rosacea: Optimizing Therapy

A supplement to Pediatric News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

To view the supplement, click the image above.

A supplement to Pediatric News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

To view the supplement, click the image above.

A supplement to Pediatric News.
Supported by an educational grant from Stiefel.
The articles in this supplement are based on presentations made during the Skin Disease Education Foundation's 29th Annual Hawaii Dermatology Seminar, on March 18-24, 2005, in Maui, Hawaii.

• The Importance of Vehicle in Acne Therapy
• Acne Management: Treatment Strategies and Challenges
• Cosmetic Management of Patients with Acne Vulgaris and Acne Rosacea
• The Resurgence of Benzoyl Peroxide in Acne Therapy
• New Treatment Options for Acne Rosacea

Faculty/Faculty Disclosure Statement

Emil A. Tanghetti, MD, Chair
Clinical Professor of Dermatology
Department of Dermatology
University of California, Davis
Medical Director
Center for Dermatology and Laser Surgery
Sacramento, Calif.
Consultant: Stiefel Laboratories, Inc.

Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, NY
Advisory Boards: Allergan, Inc., Connectics Corporation, Dermik Laboratories, Galderma International, and Medicis Pharmaceuticals Corporation.

Michael H. Gold, MD
Gold Skin Care Center
Nashville, Tenn.
No financial relationships to disclose.

Mary P. Lupo, MD
Clinical Professor of Dermatology
Tulane University Medical School
New Orleans, LA
Consultant: Stiefel Laboratories, Inc., Allergan and Dermik

Barry A. Solomon, MD, JD
Assistant Clinical Professor of Dermatology
Kings County Hospital Center
SUNY Health Science Center
Brooklyn, NY
Consultant: Stiefel Laboratories, Inc. He also discusses the investigational use of clindamycin 1% and benzoyl peroxide 5% for the treatment of acne rosacea.

Target Audience

This activity has been designed for healthcare professionals, including dermatologists and pediatricians, who are involved in the treatment of patients with acne vulgaris and acne rosacea.

Copyright © 2005 by International Medical News Group

To view the supplement, click the image above.